UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018367
Receipt number R000021265
Scientific Title Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus
Date of disclosure of the study information 2015/07/22
Last modified on 2019/01/22 10:15:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus

Acronym

Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus

Scientific Title

Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus

Scientific Title:Acronym

Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus

Region

Japan


Condition

Condition

type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabete

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

grip strength, quadriceps muscle strength

Key secondary outcomes

abdominal fat free area and visceral fat area, Hemoglobin A1C levels, pre/postprandial blood glucose levels, BMI


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Sodium-dependent glucose co-transporter 2 inhibitors(SGLT2 inhibitors)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1) Outpatients
2) Inadequate glucose control even after dietary, exercise and drug therapies for more than 8 weeks
3) HbA1c 6.5 - 10.0%
4) Fasting blood glucose levels 110 - 250mg/dl
5) Patients who themselves can voluntarily provide consent to participate in this study, and can also follow the study protocol

Key exclusion criteria

1) Type 1 diabetes
2) Had ketosis or coma within 6 month
3) Secondary diabetes
4) Patients receiving GLP-1 analogue therapy
5) Poor-controlled diabetes (HbA1c>=10.0 % or fasting blood glucose levels>=250mg/dl)
6) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months
7) Patients with complication of severe hepatic disorder, e.g., hepatocirrhosis
8) Renal insufficiency: Ccr<45 mL/min/1.73m2
9) Patients who have serious complication of gastrointestinal disorders or who underwent a surgical operation that is known to affect the absorption of a drug by digestive tract
10) Patients who are susceptible to dehydration
11) Patients who is a chronic heavy drinker
12) Patients with history of urinary infection or genital infection disease
13) Malignancies or other diseases with poor prognosis
14) Pregnant
15) Subjects whose doctor in charge do not agree to join the trial


Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Ida

Organization

Ise Red Cross Hospital

Division name

Department of Metabolic Diseases

Zip code


Address

471-2, Funae, 1-chome, Ise-shi, Mie, 516-8512

TEL

0596-28-2171

Email

bboy98762006@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Ida

Organization

Ise Red Cross Hospital

Division name

Department of Metabolic Diseases

Zip code


Address

471-2, Funae, 1-chome, Ise-shi, Mie, 516-8512

TEL

0596-28-2171

Homepage URL


Email

bboy98762006@yahoo.co.jp


Sponsor or person

Institute

Ise Red Cross Hospital
Department of Metabolic Diseases

Institute

Department

Personal name



Funding Source

Organization

Ise Red Cross Hospital
Department of Metabolic Diseases

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2015 Year 07 Month 22 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 23 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 07 Month 21 Day

Last modified on

2019 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021265


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name